UCL Institute of Ophthalmology, London, UK.
BMC Ophthalmol. 2011 Feb 8;11:5. doi: 10.1186/1471-2415-11-5.
Scotopic function is an important marker of many retinal diseases and is increasingly used as an outcome measure in clinical trials, such as those investigating gene therapy for Lebers congenital amaurosis. Scotopic visual function has traditionally been measured using an adapted perimetry system such as the Humphrey field analyser (HFA). However this system does not control for fixation errors or poor fixation stability. Here we evaluate the use of an adapted microperimeter to measure visual function at defined retinal regions under scotopic conditions.
A MP-1 microperimeter (Nidek Technologies, Italy) was modified by adding a 1 log unit Neutral Density filter and a 530 nm shortpass filter within the optical path of the instrument. Stray light was shielded. Fine matrix mapping perimetry was performed on five younger (< 35 years) and five older (> 65 years) subjects with no eye disease and good vision. All subjects were fully dark adapted before testing and pupils were dilated with 1% tropicamide. Tests was performed once on the modified MP-1 microperimeter and once using a modified HFA, in a counterbalanced order.
A foveal scotopic scotoma with a sensitivity reduction of >1 log unit was found using each instrument. In addition, the MP-1 system showed the retinal location of the foveal scotoma. Mean test time was 25 minutes for the MP-1 and 32 minutes for the HFA.
A modified MP-1 microperimeter can be used to measure scotopic retinal function, creating results which are comparable to the modified Humphrey field analyser. Advantages of the MP-1 system include the ability to track the retina through testing, retinal localisation of the scotoma and a faster test time.
暗视力功能是许多视网膜疾病的重要标志物,并且越来越多地被用作临床试验的结果衡量指标,例如针对莱伯先天性黑蒙症的基因治疗临床试验。传统上,暗视力功能是通过适应的视野计系统(如 Humphrey 视野分析仪(HFA))进行测量的。但是,该系统无法控制固视误差或固视稳定性不佳的问题。在此,我们评估了一种经过改良的微视野计在暗适应条件下测量特定视网膜区域的视觉功能的应用。
对 Nidek Technologies 公司生产的 MP-1 微视野计进行了改良,在仪器的光路中增加了 1 个对数单位的中性密度滤光片和一个 530nm 的短通滤光片。同时,对杂散光进行了屏蔽。在 5 名年龄小于 35 岁(年轻组)和 5 名年龄大于 65 岁(老年组)的无眼部疾病且视力良好的受试者中进行了精细矩阵映射视野检查。所有受试者在测试前均完全暗适应,并使用 1%托吡卡胺散瞳。以平衡顺序,分别在改良的 MP-1 微视野计和改良的 HFA 上各进行一次测试。
两种仪器均发现了一个敏感度降低超过 1 个对数单位的中心凹暗点。此外,MP-1 系统还显示了中心凹暗点的视网膜位置。MP-1 系统的平均测试时间为 25 分钟,HFA 系统的平均测试时间为 32 分钟。
改良的 MP-1 微视野计可用于测量暗视力视网膜功能,其结果与改良的 Humphrey 视野分析仪相当。MP-1 系统的优势包括在测试过程中能够跟踪视网膜、能够对暗点进行视网膜定位以及测试时间更快。